博士論文

Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on the liver natural killer cell activity in colorectal cancer with resectable liver metastasis

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on the liver natural killer cell activity in colorectal cancer with resectable liver metastasis

Persistent ID (NDL)
info:ndljp/pid/11246078
Material type
博士論文
Author
Hirata, Fumihiro
Publisher
-
Publication date
2018-08-30
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
広島大学(Hiroshima University),博士(医学)
View All

Notes on use at the National Diet Library

Notes on use

Note (General):

元資料の権利情報 : © 2018 The Authors. This is the pre-peer reviewed version of the following article: Hirata F, Ishiyama K, Tanaka Y, et al. Effect of bevaci...

Related materials as well as pre- and post-revision versions

Ann Gastroenterol Surg. 2018;2:383-393

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
Hirata, Fumihiro
Publication Date
2018-08-30
Publication Date (W3CDTF)
2018-08-30
Alternative Title
切除可能大腸癌肝転移に対するベバシツマブ併用XELOX(CapeOX)療法が肝臓内ナチュラルキラー細胞活性に与える影響
Degree grantor/type
広島大学(Hiroshima University)
Date Granted
2018-08-30
Date Granted (W3CDTF)
2018-08-30
Dissertation Number
甲第7648号